Sharps Technology, Inc. Share Price

Equities

STSS

US82003F1012

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 17/05/2024 BST 5-day change 1st Jan Change
0.2199 USD +6.64% Intraday chart for Sharps Technology, Inc. -4.31% -47.13%
Sales 2022 - Sales 2023 - Capitalization 6.35M 500M
Net income 2022 -4M -315M Net income 2023 -9M -709M EV / Sales 2022 -
Net cash position 2022 4.17M 328M Net cash position 2023 3.01M 237M EV / Sales 2023 -
P/E ratio 2022
-2.11 x
P/E ratio 2023
-0.55 x
Employees 57
Yield 2022 *
-
Yield 2023
-
Free-Float 91.49%
More Fundamentals * Assessed data
Dynamic Chart
Sharps Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia CI
Sharps Technology Planning to Collaborate with Roncadelle to Support Global Distribution and Sales of High Quality, Innovative, Safer Drug Delivery Systems CI
Sharps Technology Signs LoI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems CI
Sharps Technology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sharps Technology, Inc. announced that it has received $2.827853 million in funding CI
Sharps Technology Launches $5.6 Million Registered Direct Offering MT
Sharps Technology, Inc. announced a financing transaction CI
Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals CI
Sharps Technology, Inc. entered into a definitive agreement to acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility from Nephron Pharmaceuticals Corporation for $50 million. CI
Sharps Technology Files $200 Million Mixed Shelf MT
Sharps Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Sharps Technology Appoints Ben Scheu as Senior Director of Sales CI
Sharps Technology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Top Premarket Gainers MT
More news
1 day+6.64%
1 week-4.31%
Current month-17.92%
1 month-29.06%
3 months-30.30%
6 months-50.70%
Current year-47.13%
More quotes
1 week
0.20
Extreme 0.2
0.24
1 month
0.18
Extreme 0.18
0.30
Current year
0.18
Extreme 0.18
0.45
1 year
0.18
Extreme 0.18
1.15
3 years
0.18
Extreme 0.18
3.62
5 years
0.18
Extreme 0.18
3.62
10 years
0.18
Extreme 0.18
3.62
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14/09/21
Chairman 68 31/03/18
Director of Finance/CFO 68 30/04/19
Members of the board TitleAgeSince
Director/Board Member 64 31/08/21
Chief Executive Officer 57 14/09/21
Chairman 68 31/03/18
More insiders
Date Price Change Volume
17/05/24 0.2199 +6.64% 161,149
16/05/24 0.2062 -1.81% 178,426
15/05/24 0.21 -4.55% 67,025
14/05/24 0.22 -1.43% 30,962
13/05/24 0.2232 -2.87% 33,998

Delayed Quote Nasdaq, May 17, 2024 at 09:00 pm

More quotes
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
More about the company